Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/35
A61K-036/00
A61K-036/539
A61K-036/11
A61K-036/15
A61K-036/185
A61K-036/28
A61K-036/47
A61K-036/48
A61K-036/484
A61K-036/486
A61K-036/53
A61K-036/54
A61K-036/60
A61K-036/906
A61K-036/9062
A61K-031/353
A61K-031/7048
A61K-036/74
출원번호
US-0279925
(2006-04-17)
등록번호
US-9655940
(2017-05-23)
발명자
/ 주소
Jia, Qi
출원인 / 주소
UNIGEN, INC.
대리인 / 주소
Seed IP Law Group LLP
인용정보
피인용 횟수 :
0인용 특허 :
79
초록▼
The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provid
The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions mediated by the COX-2 and 5-LO pathways. The present invention further provides a novel method for simultaneously inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) enzymes, and reducing cox-2 mRNA production. Finally, the present invention includes a method for weight loss and blood glucose control. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier. This invention relates generally to the prevention and treatment of diseases and conditions mediated by the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) pathways, including but not limited to the relief joint discomfort and pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse.
대표청구항▼
1. A composition comprised of a mixture of an extract derived from Scutellaria enriched for Free-B-ring flavonoids containing baicalin and an extract derived from Acacia enriched for flavans containing catechin or epicatechin, wherein the ratio of Free-B-ring flavonoid:flavan in the composition is a
1. A composition comprised of a mixture of an extract derived from Scutellaria enriched for Free-B-ring flavonoids containing baicalin and an extract derived from Acacia enriched for flavans containing catechin or epicatechin, wherein the ratio of Free-B-ring flavonoid:flavan in the composition is about 85:15. 2. The composition of claim 1, wherein at least 80% of the total weight of the composition comprises Free-B-ring flavonoids and flavans. 3. The composition of claim 1, wherein the major active components of the mixture are the Free-B-ring flavonoids and the flavans. 4. The composition of claim 1, wherein the major active ingredients of the mixture are baicalin, catechin, and epicatechin. 5. The composition of claim 1, wherein the Free-B-ring flavonoids and the flavans are enriched from a plant part selected from the group consisting of stems, stem barks, trunks, trunk barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers and other reproductive organs, leaves and other aerial parts. 6. The composition of claim 1, wherein the Free-B-ring flavonoids are enriched from Scutellaria baicalensis or Scutellaria orthocalyx. 7. The composition claim 1, wherein said flavans are enriched from a plant species selected from the group consisting of the Acacia catechu, Acacia concinna, Acacia farnesiana, Acacia Senegal, Acacia speciosa, Acacia arabica, A. caesia, A. pennata, A. sinuata. A. mearnsii, A. picnantha, A. dealbata, A. auriculiformis, A. holoserecia and A. mangium. 8. The composition of claim 1, wherein the Free-B-ring flavonoids are enriched from Scutellaria baicalensis and the flavans are enriched from Acacia catechu. 9. The composition of claim 1, further comprising an adjuvant, excipient or carrier. 10. The composition of claim 9, wherein the adjuvant, excipient or carrier is selected from one or more of calcium-based salts, silica, boron, histidine, glucosamine sulfate, chondroitin sulfate, copper gluconate, cellulose, dextrose, saline, water, oil, vitamin D, and shark and bovine cartilage.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (79)
Thomas Newmark ; Paul Schulick, Anti-Inflammatory herbal composition and method of use.
Woo, Sung-Sick; Jo, Tae Hyung; Kim, Dong Seon; Sung, Sun-Young; Do, Seon-Gil; Lee, Young Chul; Nam, Jeong Bum; Ryu, Jong Ha; Lee, Kang Woo; Sung, Hee Sun; Heo, Young Moon; Oh, Mi-Sun; Cho, Ji Nyeo; Sung, Sookyoung; Lee, Ju Yeon; Kim, Tae Woo; Song, Ji Sook; Lee, Seoung Ho; Kim, Mi Ran, Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease.
Blank Robert G. (Hammonton NJ) Mody Dhiraj S. (Hammonton NJ) Kenny Richard J. (Manahawkin NJ) Aveson Martha C. (Voorhees NJ), Fast dissolving dosage forms.
Jia, Qi; Burnett, Bruce; Zhao, Yuan, Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments.
Jia, Qi; Burnett, Bruce; Zhao, Yuan, Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments.
Nair Muraleedharan G. ; Wang Haibo ; Strasburg Gale M. ; Booren Alden M. ; Gray James I., Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids.
Kang Kwon J. (101-5 Nonhyun-Dong ; Kangnam-Ku Seoul KRX), Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatme.
Ochoa Augusto C. (St. Paul MN) Bach Fritz H. (Minneapolis MN) Alter Barbara (Marine on St. Croix MN) Sondel Paul (Madison WI), Method of culturing lymphocytes and method of treatment using such lymphocytes.
Walker Edward B. (Ogden UT) Mickelsen ; Jr. Richard A. (Ogden UT) Mickelsen Jennifer N. (Ogden UT), Method of treating or preventing non-viral microbial infection.
Niebes Paul J. (Grez Doiceau BEX) Vincze Andras B. (Brussels BEX) Roba Joseph L. (Ciernont-Houyet BEX) Lambelin Georges E. (Brussels BEX) Matagne Daniel M. (Taviers BEX) Hanon Etienne T. (Brussels BE, Pharmaceutical composition and therapeutical method for treating degenerative affections of the articular cartilage.
Han Young-Bok,KRX ; Hong Eun-Kyung,KRX ; Chung Young-Shin,KRX ; Kim Sung-Jin,KRX ; Lee Kyung-Yung,KRX ; Shin Young-Lok,KRX, Pharmaceutical composition comprising an aqueous extract of a mixture of anemarrhena rhizoma and phellodedron bark for analgesic and anti-inflammation.
Han Young Bok,KRX ; Hong Eun Kyung,KRX ; Chung Young Shin,KRX ; Yoo Bo Im,KRX ; Kim Sang Geon,KRX ; Lee Kyung Yung,KRX, Pharmaceutical composition containing a mixed extract of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. for treatment of hepatitis C.
Singh Amarjit,INX ; Jain Rajesh,INX ; Singla Anil Kumar,INX, Pharmaceutical composition for the control and treatment of anorectal and colonic diseases.
Armah George Enyimah,GHX ; Achel Daniel Gyingiri,GHX ; Acquaah ; deceased Robert Asare,GHX ITX by Elizabeth Acquaah ; executor ; Belew Makonnen,SEX, Purification of miraculin glycoprotein using tandem hydrophobic interaction chromatography.
Bath Teresa K. ; Lynch Neal, Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue.
Van Scott Eugene J. (1138 Sewell Lane Rydal PA 19046) Yu Ruey J. (4400 Dexter St. Philadelphia PA 19128), Treatment of acne utilizing N-methyldiethanolamine.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.